Editas Medicine, Inc. - Common Stock — datos financieros trimestrales (NASDAQ:EDIT)

Financials

Flujo de caja de las actividades operativas -50.76 M-47.8 M-50.21 M-30.84 M-36.39 M-23.06 M -140.5 M Flujo de caja de las actividades de inversión 30.96 M56.39 M42.65 M39.57 M58 K64 K 82.34 M Flujo de caja de las actividades financieras 55.51 M-1.44 M7.41 M17.17 M17.33 M0 41.91 M Flujo de caja libre -50.76 M-47.8 M-50.21 M-30.84 M-36.39 M-23.06 M -140.5 M

Editas Medicine, Inc. - Common Stock

Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

EDIT

Financials

Editas Medicine, Inc. - Common Stock

Noticias

Editas Medicine: Resetting Pipeline Just To Be Second To Market Again (NASDAQ:EDIT)

Las acciones de Editas Medicine caen tras anuncio de oferta de valores

Editas Medicine lanza una oferta pública de acciones y warrants

Editas presenta datos preclínicos de su tratamiento de edición genética

Editas Medicine presenta datos preclínicos de su terapia EDIT-401

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

Company News for May 6, 2026

Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates

Editas Medicine presentará datos preclínicos sobre la terapia EDIT-401

Why Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?